Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/15/2025 | $75.00 | Underperform → Neutral | BofA Securities |
4/14/2025 | $81.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
2/13/2025 | $85.00 → $89.00 | Underweight → Equal Weight | Barclays |
1/17/2025 | $91.00 | Peer Perform → Outperform | Wolfe Research |
10/7/2024 | $88.00 → $84.00 | Equal Weight → Underweight | Barclays |
5/28/2024 | $85.00 → $95.00 | Neutral → Buy | Citigroup |
5/24/2024 | $80.00 → $103.00 | Equal Weight → Overweight | Wells Fargo |
5/23/2024 | $96.00 | Market Perform → Outperform | BMO Capital Markets |
WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c
Dr. Deyan Wang and Nicholas Sands Recognized for a Career of Innovation and Business Impact; Achieve Highest Technical Level in the Company WILMINGTON, Del., Oct. 10, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that two of its technology leaders have achieved the professional distinction of DuPont Laureate, the company's most distinguished technical designation. The newly appointed Laureates are Dr. Deyan Wang, DuPont Electronics & Industrial and Nicholas (Nick) Sands of DuPont Water & Protection. "I'm tremendously honored to recognize Deyan and Nick, two of DuPont's
Transaction deepens healthcare offerings in medical device solutions WILMINGTON, Del., June 25, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has signed an agreement to acquire Donatelle Plastics Incorporated, a leading medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. "Our healthcare strategy is focused on offering a comprehensive sui
WILMINGTON, Del., April 18, 2025 /PRNewswire/ -- DuPont (NYSE:DD) will release its first quarter financial results at 6:00 a.m. ET on Friday, May 2, 2025. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website. The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046. About DuPo
Karin De Bondt and Anne Noonan to serve as independent directors WILMINGTON, Del., April 16, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that Karin De Bondt and Anne Noonan will become members of the future board of directors (the "Electronics Board") for the independent Electronics public company that will be created following its intended spin-off from DuPont, which is targeted for November 1, 2025. Ms. De Bondt is Senior Vice President and Chief Strategy Officer for Trane Technologies, a global climate innovator that brings efficient and sustainable climate soluti
SEOUL, South Korea, April 16, 2025 /PRNewswire/ -- DuPont will showcase its state-of-the-art products that incorporate silver nanowire technologies in Hall D, Booth A31 at Electronics Manufacturing Korea (EMK) and Automotive World Korea (AWK) exhibitions from April 16 to 18. DuPont has expanded its innovative product portfolio into material solutions for transparent heaters, smart surfaces, Advanced Driver Assistance System (ADAS), in-mold electronics (IME), transparent electromagnetic interference (EMI) shielding and infrared (IR) reflecting, and other applications in automotive and consumer electronics sectors.
8-K - DuPont de Nemours, Inc. (0001666700) (Filer)
DEFA14A - DuPont de Nemours, Inc. (0001666700) (Filer)
DEF 14A - DuPont de Nemours, Inc. (0001666700) (Filer)
WILMINGTON, Del., April 18, 2025 /PRNewswire/ -- DuPont (NYSE:DD) will release its first quarter financial results at 6:00 a.m. ET on Friday, May 2, 2025. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website. The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046. About DuPo
WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that its Board of Directors has declared a quarterly dividend of forty-one cents ($0.41) per share on the outstanding Common Stock (par value $0.01 per share), representing an 8% increase to its 2024 quarterly dividends, payable on March 17, 2025, to holders of record of said stock at the close of business on March 3, 2025.(1) (1) Future dividends are at the discretion of the DuPont Board of Directors. About DuPontDuPont (NYSE:DD) is a global innovation leader with technology-based materials and s
Fourth Quarter 2024 Highlights Net Sales of $3.1 billion increased 7%; organic sales increased 7% versus year-ago periodGAAP Loss from continuing operations of $(61) million, operating EBITDA of $807 millionGAAP EPS from continuing operations of $(0.17); adjusted EPS of $1.13Cash provided by operating activities from continuing operations of $564 million; transaction-adjusted free cash flow of $455 millionFull Year 2024 Highlights Net Sales of $12.4 billion increased 3%; organic sales increased 1% versus prior yearGAAP Income from continuing operations of $778 million; operating EBITDA of $3.14 billionGAAP EPS from continuing operations of $1.77; adjusted EPS of $4.07Cash provided by operati
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)
SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)
SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)
SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)
BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00
KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00
Barclays upgraded DuPont from Underweight to Equal Weight and set a new price target of $89.00 from $85.00 previously